Society · en
FDA to require vision loss warning on GLP-1 drug labels
The labelling requirement stems from the findings of a 2024 study and subsequent FDA trials that tested the results of that study.
Related index pages
Technology · Ars TechnicaFDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.Read original ↗
Technology · Sky News TechnologyFDA orders blindness risk warning on weight loss drugs
Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to add a warning label about a rare eye condition that can cause blindness, the US…Read original ↗
World · Nikkei AsiaJapan Tobacco shares tumble on fears of $8bn Russia loss
TOKYO -- Shares in Japan Tobacco have sold off as investors price in a potential loss as big as roughly 1.3 trillion yen ($8.2 billion) on the cigaretRead original ↗
Technology · BBC NewsClaude chatbot maker set for $1.3tn stock market debut despite 'catastrophic' AI warning
The AI company behind the Claude chatbot will offer its shares at between $70 and $78, which is lower than what was expected.Read original ↗
Technology · Nikkei AsiaSoftBank swings to first-half loss as AI hopes face new setbacks
TOKYO -- SoftBank Group on Tuesday swung to a first-half net loss, as it faces growing uncertainty over its ambitious artificial intelligence strategyRead original ↗
World · BBC News